Epigenetic Drug Effects in Levodopa-Treated Patients with Parkinson's Disease

Affiliations

¹ Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Berlin, Germany.
² Department of Neurology, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany.

Comment

Thomas Müller et al. Mov Disord. 2023 Apr.

. 2023 Apr;38(4):710-711.

doi: 10.1002/mds.29365.

¹ Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Berlin, Germany.
² Department of Neurology, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany.

No abstract available

Comment in

Reply to: "Epigenetic Drug Effects in Levodopa Treated Patients with Parkinson's Disease".
Yang X, Xiao Q. Yang X, et al. Mov Disord. 2023 Apr;38(4):711. doi: 10.1002/mds.29368. Mov Disord. 2023. PMID: 37061883 No abstract available.

Parkinson's Disease Is Associated with Impaired Gut-Blood Barrier for Short-Chain Fatty Acids.
Yang X, Ai P, He X, Mo C, Zhang Y, Xu S, Lai Y, Qian Y, Xiao Q. Yang X, et al. Mov Disord. 2022 Aug;37(8):1634-1643. doi: 10.1002/mds.29063. Epub 2022 May 24. Mov Disord. 2022. PMID: 35607987
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
Xie A, Ensink E, Li P, Gordevičius J, Marshall LL, George S, Pospisilik JA, Aho VTE, Houser MC, Pereira PAB, Rudi K, Paulin L, Tansey MG, Auvinen P, Brundin P, Brundin L, Labrie V, Scheperjans F. Xie A, et al. Mov Disord. 2022 Aug;37(8):1644-1653. doi: 10.1002/mds.29128. Epub 2022 Jun 20. Mov Disord. 2022. PMID: 35723531 Free PMC article.